Acorah Software Products - Accounts Production 16.8.310 false true 30 April 2024 1 May 2023 false true No description of principal activity 1 May 2024 30 April 2025 30 April 2025 11301617 Beverly Tsai-Goodman iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11301617 2024-04-30 11301617 2025-04-30 11301617 2024-05-01 2025-04-30 11301617 frs-core:CurrentFinancialInstruments 2025-04-30 11301617 frs-bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 11301617 frs-bus:FilletedAccounts 2024-05-01 2025-04-30 11301617 frs-bus:Micro-entities 2024-05-01 2025-04-30 11301617 frs-bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 11301617 frs-bus:Director1 2024-05-01 2025-04-30 11301617 2023-04-30 11301617 2024-04-30 11301617 2023-05-01 2024-04-30 11301617 frs-core:CurrentFinancialInstruments 2024-04-30
Registered number: 11301617
BTG Cardiology Limited
Unaudited Financial Statements
For The Year Ended 30 April 2025
Balance Sheet
Registered number: 11301617
2025 2024
£ £
Fixed assets 302 884
Current assets 109,534 80,468
Creditors: Amounts Falling Due Within One Year (3,611 ) (4,800 )
NET CURRENT ASSETS 105,923 75,668
TOTAL ASSETS LESS CURRENT LIABILITIES 106,225 76,552
NET ASSETS 106,225 76,552
CAPITAL AND RESERVES 106,225 76,552

Notes

1. General Information
BTG Cardiology Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11301617 . The registered office is 86 Shirehampton Road, Stoke Bishop, Bristol, BS9 2DR.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Beverly Tsai-Goodman
Director
18/01/2026